Portland, ORNCT05951049Now EnrollingIRB Ready

Systemic Amyloidosis Clinical Trial in Portland, OR

Access cutting-edge systemic amyloidosis treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.

Sponsored by Attralus, Inc.

Quick Self-Assessment

See if you qualify for this Portland location

Preparing your pre-screening questions...

Expert Care in Portland

Access systemic amyloidosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related systemic amyloidosis treatment provided free

Apply for This Portland Location

Check if you qualify for this systemic amyloidosis clinical trial in Portland, OR

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Portland

    Convenient for OR residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Portland site if eligible
  4. 4Begin participation

About This Systemic Amyloidosis Study in Portland

This is a Phase 2 open-label extension study to evaluate the long-term safety, tolerability, and clinical activity of AT-02. AT-02 is an investigational medicinal product being developed to treat systemic amyloidosis.

Sponsor: Attralus, Inc.

Who Can Participate

Inclusion Criteria

Subject understands the study procedures and can give signed informed consent. 2. Subject is willing and able to comply with this protocol and will be available for the entire duration of the study. 3. Has a confirmed diagnosis of AL amyloidosis and meets the criteria below: 1. Histologic confirmation with a biopsy containing deposits of apple-green birefringent, Congophilic material or other amyloid staining (i.e., thioflavin T or sulfated alcian blue) with confirmatory immunohistochemistry or mass spectrometry, AND 2. May be receiving maintenance daratumumab and must have achieved and maintained a hematologic very good partial response (VGPR) or complete response (CR), have completed chemotherapy therapy (ie, melphalan, bortezomib, thalidomide, lenalidomide, or cyclophosphamide) and be at least 6 months from first hematologic response (CR or VGPR), AND 3. Either <!-- --> 1. Screening eGFR ≥20 and ≤75 mL/min/1.73m2 based on CKD-EPI equation, O

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Portland?

Yes, this clinical trial (NCT05951049) has an active research site in Portland, OR that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Systemic Amyloidosis Treatment Options in Portland, OR

If you're searching for systemic amyloidosis treatment options in Portland, OR, this clinical trial (NCT05951049) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced systemic amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all systemic amyloidosis clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Portland, OR

See all heart attack clinical trials recruiting in Portland — not just this study.

Browse Heart Attack Trials in Portland

Ready to Join in Portland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Portland, OR